MNPRMonopar Therapeutics Inc.
$83.72-15% 1Y
$83.72
$50.1252 weeks$124.25
The financials
Monopar Therapeutics Inc. by the numbers
Monopar Therapeutics Inc. (MNPR) reported revenue of $0 in Q2 2026 (quarter ended Jun 30, 2026). That came with net loss of $5.3M. For the full year FY2025, revenue was $0 and net income −$14M. The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $0 | n/a | n/a |
| Operating income | −$6.6M | −$3.2M | n/a |
| Net income | −$5.3M | −$2.5M | n/a |